ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,714Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 1278

$278K Total Retail Price of All Prescriptions

Rank: 394 out of 1278

442 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

8% of this provider’s 3,456 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
OXYCODONE-ACETAMINOPHEN 521 165 S2 1 29
LISINOPRIL 500 214 2 1
IBUPROFEN 297 137 3 46
AMLODIPINE BESYLATE 292 161 4 5
CARISOPRODOL 277 62 R 5 51
LOVASTATIN 270 122 6 13
OMEPRAZOLE 247 59 7 6
GLYBURIDE 237 103 R 8 40
METFORMIN HCL 231 80 9 4
TRAMADOL HCL 204 42 10 25
SIMVASTATIN 198 83 11 3
PROAIR HFA 183 62 12 26
LEVOTHYROXINE SODIUM 180 75 13 2
CYCLOBENZAPRINE HCL 179 58 R 14 62
RANITIDINE HCL 171 48 15 20
ATENOLOL 154 80 16 11
AMOX TR-POTASSIUM CLAVULANATE 146 51 17 102
METOPROLOL TARTRATE 142 64 18 9
FUROSEMIDE 104 66 19 10
TRAZODONE HCL 102 38 20 38
HYDROCODONE-ACETAMINOPHEN 100 60 S3 21 7
CLONIDINE HCL 100 21 21 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 23 21 30
FLUTICASONE PROPIONATE 96 26 24 24
HYDROXYZINE HCL 94 16 R 25 151
ATORVASTATIN CALCIUM 89 33 26 15
POTASSIUM CHLORIDE 82 23 27 21
TERAZOSIN HCL 76 57 28 59
CITALOPRAM HBR 73 18 29 22
METOPROLOL SUCCINATE 70 14 30 23
HYDROCHLOROTHIAZIDE 68 19 31 8
GABAPENTIN 64 26 32 12
PROMETHAZINE HCL 64 28 R 32 111
WARFARIN SODIUM 63 17 34 17
GEMFIBROZIL 62 14 35 54
INSULIN SYRINGE 59 0 36 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 19 36 90
LANTUS 58 17 38 33
CLOTRIMAZOLE-BETAMETHASONE 58 29 38 205
GLIPIZIDE 58 23 38 35
AZITHROMYCIN 58 18 38 37
ALENDRONATE SODIUM 57 37 42 18
ALLOPURINOL 56 0 43 36
ACTOS 54 32 44 72
SPIRONOLACTONE 53 29 45 78
ADVAIR DISKUS 52 29 46 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.